CoChat

Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification

Rosado, Jason, Han, Jiru, Obadia, Thomas, Munro, Jacob, Traore, Zeinabou, Schoffer, Kael, Brewster, Jessica, Bourke, Caitlin, Vinetz, Joseph M., Taylor, Aimee R., White, Michael, Bahlo, Melanie, Gamboa, Dionicia, Mueller, Ivo, Ruybal-Pesántez, Shazia · 2025
PreprintCited by 6

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Summary: Plasmodium vivax infections are characterised by recurrent bouts of blood-stage parasitaemia. Understanding the genetic relatedness of recurrences can help distinguish whether these are caused by relapse, reinfection, or recrudescence, which is critical to understand treatment efficacy and transmission dynamics. We developed PvAmpseq, an amplicon sequencing assay targeting 11 SNP-rich regions of the P. vivax genome. PvAmpSeq was applied to field isolates from a clinical trial in the Solomon Islands and a longitudinal observational cohort in Peru, and statistical models were applied for genetic classification of recurrences. In the Solomon Islands trial, where participants received antimalarials at baseline, half of the recurrent infections were caused by parasites with >50% relatedness to the baseline infection (identity-by-descent), with statistical models providing further classification as probable relapses and recrudescences, although with wide uncertainty. In the Peruvian cohort, half of the recurrent infections were caused by parasites with >22% relatedness to the baseline infection. PvAmpSeq provides high-resolution genotyping to characterise P. vivax recurrences, offering insights into transmission and treatment outcomes. We also discuss the nuances and limitations of available statistical methods for the classification of P. vivax genotyping data. Graphical abstract: Created in BioRender. Rosado, J. (2026) https://BioRender.com/p66i686

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2025.05.26.25327775

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 63

  1. 10.1371/journal.pmed.1001891 · DOI · Paper page
  2. 2019, Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs, Sci. Rep, 9, 17790, 10.1038/s41598-019-54203-0 · doi:10.1038/s41598-019-54203-0
  3. 2025, Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages, Nat. Commun, 16, 7192, 10.1038/s41467-025-62357-x · DOI · Paper page
  4. 10.1186/s12864-017-4260-y · DOI
  5. 10.1016/j.pt.2023.11.006 · DOI · Paper page
  6. 10.1038/s41598-019-39656-7 · DOI · Paper page
  7. 10.1093/infdis/jiv142 · DOI
  8. 10.12688/wellcomeopenres.17736.2 · doi:10.12688/wellcomeopenres.17736.2
  9. 10.1128/AAC.00437-21 · doi:10.1128/aac.00437-21
  10. 2021, Unraveling the Complexity of Imported Malaria Infections by Amplicon Deep Sequencing, Front. Cell. Infect. Microbiol, 11, 725859, 10.3389/fcimb.2021.725859 · DOI
  11. 10.1093/infdis/jiac144 · DOI · Paper page
  12. 2024, Using a mobile nanopore sequencing lab for end-to-end genomic surveillance of Plasmodium falciparum: A feasibility study. PLOS Glob, Public Health, 4, e0002743
  13. 10.1111/1755-0998.13622 · DOI
  14. 2023, Molecular Surveillance of Malaria Using the PF AmpliSeq Custom Assay for Plasmodium falciparum Parasites from Dried Blood Spot DNA Isolates from Peru, Bio Protoc, 13, e4621
  15. 2023, Malaria Molecular Surveillance in the Peruvian Amazon with a Novel Highly Multiplexed Plasmodium falciparum AmpliSeq Assay, Microbiol. Spectr, 11, e0096022, 10.1128/spectrum.00960-22 · DOI
  16. 10.1128/AAC.02474-17 · DOI
  17. 2022, Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh, Malar. J, 21, 218, 10.1186/s12936-022-04236-0 · DOI
  18. 2024, Genetic diversity of Plasmodium vivax population in northeast Myanmar assessed by amplicon sequencing of PvMSP1 and PvMSP3α, Acta Trop, 260, 107461, 10.1016/j.actatropica.2024.107461 · DOI
  19. 2025, Molecular epidemiology and genetic diversity of disappearing Plasmodium vivax in southern Thailand, Sci. Rep, 15, 2620, 10.1038/s41598-025-86578-8 · DOI
  20. 2023, Amplicon deep sequencing of five highly polymorphic markers of Plasmodium falciparum reveals high parasite genetic diversity and moderate population structure in Ethiopia, Malar. J, 22, 376, 10.1186/s12936-023-04814-w · DOI
  21. 2023, Genetic diversity and molecular evolution of Plasmodium vivax Duffy Binding Protein and Merozoite Surface Protein-1 in northwestern Thailand, Infect. Genet. Evol, 113, 105467, 10.1016/j.meegid.2023.105467 · doi:10.1016/j.meegid.2023.105467
  22. 10.1038/s41467-023-39417-1 · DOI
  23. 2024, Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites, Nat. Commun, 15, 6757, 10.1038/s41467-024-51015-3 · DOI · Paper page
  24. 2022, Novel highly-multiplexed AmpliSeq targeted assay for Plasmodium vivax genetic surveillance use cases at multiple geographical scales, Front. Cell. Infect. Microbiol, 12, 953187, 10.3389/fcimb.2022.953187 · DOI
  25. 10.1371/journal.pntd.0011879 · DOI
  26. 2024, High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes, Nat. Commun, 15, 10219, 10.1038/s41467-024-54731-y · DOI · Paper page
  27. 10.1101/2025.04.30.25326751 · doi:10.1101/2025.04.30.25326751
  28. 10.3389/fmala.2025.1604498 · DOI
  29. 10.1371/journal.pntd.0009165 · DOI
  30. 10.12688/f1000research.129581.1 · doi:10.12688/f1000research.129581.1
  31. 2021, Temporal and Microspatial Heterogeneity in Transmission Dynamics of Coendemic Plasmodium vivax and Plasmodium falciparum in Two Rural Cohort Populations in the Peruvian Amazon, J. Infect. Dis, 223, 1466, 10.1093/infdis/jiaa526 · DOI
  32. 2017, High prevalence of very-low Plasmodium falciparum and Plasmodium vivax parasitaemia carriers in the Peruvian Amazon: insights into local and occupational mobility-related transmission, Malar. J, 16, 415, 10.1186/s12936-017-2063-x · DOI
  33. 10.1186/1475-2875-9-361 · DOI · Paper page
  34. 10.1038/ng.3599 · DOI · Paper page
  35. 10.1093/bioinformatics/btp352 · DOI · Paper page
  36. 10.1093/nar/gks596 · DOI · Paper page
  37. 10.1093/bioinformatics/btp450 · DOI · Paper page
  38. 10.1590/s0074-02762009000100011 · DOI
  39. 10.1371/journal.pntd.0007876 · DOI
  40. 10.1093/genetics/iyac126 · DOI · Paper page
  41. 10.1093/bioinformatics/btaf643 · DOI · Paper page
  42. 10.1186/1475-2875-10-297 · DOI · Paper page
  43. 10.1016/j.pt.2013.05.004 · DOI
  44. 2021, Anti-malarial drug effects on parasite dynamics in vivax malaria, Malar. J, 20, 161, 10.1186/s12936-021-03700-7 · DOI
  45. 10.1179/2047773215Y.0000000012 · doi:10.1179/2047773215y.0000000012
  46. 10.1093/infdis/jir806 · DOI · Paper page
  47. 10.1086/512242 · DOI · Paper page
  48. 2022, Hypnozoite depletion in successive Plasmodium vivax relapses, PLoS Negl. Trop. Dis, 16, e0010648, 10.1371/journal.pntd.0010648 · DOI
  49. 10.1186/1475-2875-13-8 · doi:10.1186/1475-2875-13-8
  50. 10.1186/s13073-018-0563-0 · DOI · Paper page
  51. 10.1093/infdis/jis391 · doi:10.1093/infdis/jis391
  52. 10.1371/journal.pone.0049871 · doi:10.1371/journal.pone.0049871
  53. 10.1371/journal.pone.0066041 · DOI
  54. 10.1186/1475-2875-12-429 · DOI
  55. 10.1128/mBio.01888-17 · DOI
  56. 10.1056/NEJMc2023884 · doi:10.1056/nejmc2023884
  57. 2019, Resolving the cause of recurrent Plasmodium vivax malaria probabilistically, Nat. Commun, 10, 5595, 10.1038/s41467-019-13412-x · DOI · Paper page
  58. 10.1086/512677 · DOI · Paper page
  59. 2008, Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria, Am. J. Trop. Med. Hyg, 79, 378, 10.4269/ajtmh.2008.79.378 · DOI
  60. 10.1128/CMR.00051-10 · DOI · Paper page
  61. 2017, Malaria eradication and the hidden parasite reservoir, Trends Parasitol, 33, 492, 10.1016/j.pt.2017.03.002 · doi:10.1016/j.pt.2017.03.002
  62. 10.1186/s12936-016-1641-7 · doi:10.1186/s12936-016-1641-7
  63. 10.1371/journal.pntd.0002882 · DOI · Paper page

Cited by

See all 6

Metadata

Authors
Rosado, J., Han, J., Obadia, T., Munro, J., Traore, Z., Schoffer, K., Brewster, J., Bourke, C., Vinetz, J. M., Taylor, A. R., White, M., Bahlo, M., Gamboa, D., Mueller, I., & Ruybal-Pesántez, S.
Publisher
openRxiv
Published
2025-05-26
Cited by
6
References
1
Type
Preprint

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification. https://app.cochat.ai/papers/10.1101/2025.05.26.25327775
The paper
Rosado, J., Han, J., Obadia, T., Munro, J., Traore, Z., Schoffer, K., Brewster, J., Bourke, C., Vinetz, J. M., Taylor, A. R., White, M., Bahlo, M., Gamboa, D., Mueller, I., & Ruybal-Pesántez, S. (2025). Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification. https://doi.org/10.1101/2025.05.26.25327775

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.